AbbVie Enters Strategic Alliance with iSTAR Medical for MINIject with Option to Acquire
July 20, 2022
AbbVie has entered into a strategic alliance with iSTAR Medical to further develop and commercialize the MINIject minimally invasive glaucoma surgery (MIGS) device. iSTAR will receive a $60M non-dilutive upfront payment and AbbVie holds an exclusive right to acquire iSTAR, with up to $475M of additional contingent payments tied to closing and milestones; iSTAR will remain independent until completion of its STAR‑V study.
- Buyers
- AbbVie
- Targets
- iSTAR Medical
- Industry
- Medical Devices
- Location
- Belgium
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Boston Scientific Makes $1.5 Billion Investment in MiRus LLC for Option to Acquire TAVR Business
May 18, 2026
Medical Devices
Boston Scientific Corporation invested $1.5 billion for an approximately 34% equity stake in privately held MiRus LLC. Under the investment agreement, Boston Scientific received an exclusive option to acquire MiRus’s SIEGEL balloon-expandable TAVR system business for up to $3 billion in additional cash payments, subject to clinical and regulatory milestones and closing conditions.
-
Alcon Agrees to Acquire STAAR Surgical Company
October 15, 2025
Healthcare Services
Alcon entered into a definitive merger agreement to acquire STAAR Surgical Company for $28.00 per share in cash, valuing the deal at approximately $1.5 billion. The transaction includes STAAR’s EVO family of implantable collamer lenses (EVO ICL) and is expected to close in about six to 12 months, subject to regulatory approval and STAAR shareholder approval.
-
Bausch + Lomb Acquires Elios Vision
December 11, 2024
Medical Devices
Bausch + Lomb Corporation (through an affiliate) has acquired Elios Vision, Inc., developer of the ELIOS excimer-laser MIGS system, expanding Bausch + Lomb's glaucoma surgical capabilities and complementing its cataract surgery portfolio. The ELIOS technology, currently CE marked and marketed in the EU, is undergoing pursuit of FDA approval and will be commercialized more broadly through Bausch + Lomb's global cataract surgery channels.
-
Stryker Acquires Vertos Medical Inc.
August 22, 2024
Medical Devices
Stryker has entered into a definitive agreement to acquire Vertos Medical Inc., a privately held company that develops the minimally invasive Mild® procedure for treating lumbar spinal stenosis. The acquisition expands Stryker’s interventional pain management and minimally invasive treatment portfolio and extends its reach into ambulatory surgery centers; the transaction remains subject to customary closing conditions.
-
Astellas Acquires IVERIC bio for Approximately $5.9 Billion
April 29, 2023
Biotechnology
Astellas Pharma has agreed to acquire 100% of IVERIC bio for $40.00 per share, implying an aggregate equity value of roughly $5.9 billion. The acquisition strengthens Astellas' ophthalmology capabilities and adds Iveric's lead program avacincaptad pegol (ACP) for geographic atrophy secondary to AMD to Astellas' pipeline.
-
ABRY Partners Acquires International Medical Group (IMG)
September 15, 2015
Healthcare Services
International Medical Group, Inc. (IMG) has signed a definitive agreement to be acquired by ABRY Partners, a private equity firm headquartered in Boston, Massachusetts. The companies said IMG’s operations will continue without disruption, and financial terms of the deal were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.